Metabolic HealthVisceral Fat Loss Cuts Type 2 Diabetes Risk 28% Even After Weight Regain
A landmark follow-up study tracked participants from two major diet-and-exercise clinical trials for up to 10 years using MRI scans. Even though most participants regained their lost weight, those who had reduced visceral fat during the original interventions retained meaningful cardiometabolic benefits. Critically, each 10% reduction in visceral fat achieved during the 18-month intervention was associated with a 28% lower risk of developing type 2 diabetes over the following decade. Abdominal fat depots partially preserved their improvements long-term, while liver fat was fully regained and pancreatic fat was regained beyond baseline. The findings reframe the goal of lifestyle medicine: visceral fat reduction, independent of the number on the scale, may be the true driver of durable metabolic health.
